Jazz Pharmaceuticals Director Patrick Enright Sells 1,706 Shares

What Happened Patrick G. Enright, a director of Jazz Pharmaceuticals plc (JAZZ), had 1,706 shares disposed on August 31, 2026. The sales were to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units (RSUs). The transactions consisted of 14 shares at $244.64 (≈ $3,425) and 1,692 shares at $241.39 (≈ $408,432), totaling roughly $412,000. This was not a discretionary open-market sell for cash or investment reasons but a routine withholding sale to cover taxes.

Key Details

• Transaction date: 2026-08-31
• Trades:
  • 14 shares sold at $244.64 each — proceeds ≈ $3,425
  • 1,692 shares sold at $241.39 each — proceeds ≈ $408,432
• Transaction code: F (payment of exercise price or tax liability)
• Footnote: Shares were sold to satisfy tax obligations from vested RSUs (F1).
• Filing: Reported on SEC Form 4 filed 2026-09-02 — appears timely relative to the 8/31 transaction.
• Shares owned after the transaction: not specified in the provided filing.

Context

• These sales were tax-withholding related to RSU vesting (common practice); they generally do not signal a director buying or selling shares for investment reasons.
• For retail investors: purchases or voluntary sales tend to be more informative about insider sentiment; withholding sales are routine and primarily administrative.